Mylan   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: White Sulfur Springs WV United States (1961)
Status: No NME R&D (1961)

Organization Overview

First Clinical Trial
1999
NCT00142545
First Marketed Drug
1961
butabarbital (neonal)
First NDA Approval
1965
sulfanilamide (avc)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MLV | MYLAN | MYLAN ASI | MYLAN BERTEK | Mylan Bertek Pharmaceuticals | Mylan Bertek Pharmaceuticals Inc. | Mylan GmbH | MYLAN GMBH | Mylan Inc. | MYLAN INSTITUTIONAL | MYLAN IRELAND LTD | Mylan Laboratories | MYLAN LABS | MYLAN LABS INC | MYLAN LABS LTD | MYLAN PHARMA | Mylan Pharmaceuitcals Inc. | Mylan Pharmaceutials | Mylan Pharmaceuticals | MYLAN PHARMS INC | MYLAN SPCLT VIATRIS | MYLAN SPECIALITY LP | Mylan Specialty L.P. | MYLAN SPECLT | MYLAN TECHNOLOGIES | Mylan Technologies Inc. | MYLAN TECH VIATRIS | MYLAN TEORANTA | PVT FORM | Synerx Pharma, LLC